Success in the Academy

Toward Integration of Molecular Measures and Artificial Intelligence-Based Assessments With Clinical End Points in Inflammatory Bowel Disease

Reinisch W. et al, (2026), Gastroenterology, 170, 686 - 703

Therapeutic manipulation and spatial quantification of the tumor microenvironment in colorectal cancer.

Mulholland-Illingworth EJ. et al, (2026), iScience, 29

Upstream ORFs control TNFR1 abundance and tissue tolerance to TNF.

Ma B. et al, (2026), Science immunology, 11

Hypoxic regulation of chromatin and gene transcription

Kindrick JD. et al, (2026), Communications Biology

Chromosomal instability shapes the tumor microenvironment of esophageal adenocarcinoma via a cGAS–chemokine–myeloid axis

Beernaert B. et al, (2026), Science Advances, 12

The RNA-binding protein SRSF3 controls epicardial formation by regulating splicing and proliferation

Lupu I-E. et al, (2026), Development, 153

Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease in a Cohort of Patients With Chronic Hepatitis B

Kalafateli M. et al, (2026), Clinical Gastroenterology and Hepatology, 24, 701 - 712.e8

The Role of Fibroblast–Epithelial Cross-Talk on the Distribution of Distinct Fibroblast Phenotypes in the Intestinal Crypt

Atkinson G. et al, (2026), Bulletin of Mathematical Biology, 88

comBO: A combined human bone and lympho-myeloid bone marrow organoid for preclinical modeling of hematopoietic disorders

Shen Y. et al, (2026), Cell Stem Cell, 33, 421 - 437.e7

Topological model selection: a case-study in tumour-induced angiogenesis.

McDonald RA. et al, (2026), Bioinformatics (Oxford, England)

Self-supervised Monocular Depth and Pose Estimation for Endoscopy with Latent Priors.

Xu Z. et al, (2026), IEEE transactions on medical imaging, PP

Mutational Signatures and Clonal Hematopoiesis in Intestinal Metaplasia across Countries with Varying Stomach Cancer Incidence.

Huang KK. et al, (2026), Cancer discovery, 16, 497 - 520

JAK2V617F reprograms Hypoxia Inducible Factor-1 to induce a non-canonical hypoxia regulon in myeloproliferative neoplasms.

Kealy D. et al, (2026), Leukemia, 40, 609 - 621

Rapid and durable recovery of immune effector cells in myelofibrosis patients treated with momelotinib.

Makker J. et al, (2026), Haematologica, 111, 1096 - 1099

Mathematical modelling and analysis of unsteady poroelastohydrodynamics for an in-vivo type solid tumour.

Alam M. et al, (2026), Journal of mathematical biology, 92

Discrete genetic effects of VHL and PBRM1 inactivation co-operate to disrupt epithelial homeostasis and promote ccRCC

Kurlekar S. et al, (2026)

ACE2 inhibition ELISA is an effective surrogate for SARS-CoV-2 live virus neutralisation

Tipton T. et al, (2026), Vaccine, 72, 128123 - 128123

When, which and how to switch: Navigating JAK inhibitors in myelofibrosis

O'Sullivan J. et al, (2026), British Journal of Haematology, 208, 437 - 441

Response to Comments on ‘Hepatitis B Virus ( HBV ) Treatment Eligibility in the UK : Retrospective Longitudinal Cohort Data to Explore the Impact of Changes in Clinical Guidelines’

Campbell C. et al, (2026), Journal of Viral Hepatitis, 33

Restoring Function to a Variant of p53 in Solid Tumors.

Lu X., (2026), The New England journal of medicine, 394, 922 - 925

Search results

Showing results for